118 related articles for article (PubMed ID: 17726260)
1. Expression of integrin alpha10 is induced in malignant melanoma.
Wenke AK; Kjellman C; Lundgren-Akerlund E; Uhlmann C; Haass NK; Herlyn M; Bosserhoff AK
Cell Oncol; 2007; 29(5):373-86. PubMed ID: 17726260
[TBL] [Abstract][Full Text] [Related]
2. Expression of integrin alpha 10 is transcriptionally activated by pRb in mouse osteoblasts and is downregulated in multiple solid tumors.
Engel BE; Welsh E; Emmons MF; Santiago-Cardona PG; Cress WD
Cell Death Dis; 2013 Nov; 4(11):e938. PubMed ID: 24287699
[TBL] [Abstract][Full Text] [Related]
3. Regulation of integrin alpha10 expression in chondrocytes by the transcription factors AP-2epsilon and Ets-1.
Wenke AK; Rothhammer T; Moser M; Bosserhoff AK
Biochem Biophys Res Commun; 2006 Jun; 345(1):495-501. PubMed ID: 16684505
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration.
Rothhammer T; Poser I; Soncin F; Bataille F; Moser M; Bosserhoff AK
Cancer Res; 2005 Jan; 65(2):448-56. PubMed ID: 15695386
[TBL] [Abstract][Full Text] [Related]
5. The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma.
Rothhammer T; Hahne JC; Florin A; Poser I; Soncin F; Wernert N; Bosserhoff AK
Cell Mol Life Sci; 2004 Jan; 61(1):118-28. PubMed ID: 14704859
[TBL] [Abstract][Full Text] [Related]
6. TANGO is a tumor suppressor of malignant melanoma.
Arndt S; Bosserhoff AK
Int J Cancer; 2006 Dec; 119(12):2812-20. PubMed ID: 17044017
[TBL] [Abstract][Full Text] [Related]
7. Expression of Hugl-1 is strongly reduced in malignant melanoma.
Kuphal S; Wallner S; Schimanski CC; Bataille F; Hofer P; Strand S; Strand D; Bosserhoff AK
Oncogene; 2006 Jan; 25(1):103-10. PubMed ID: 16170365
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
Mueller DW; Bosserhoff AK
Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
[TBL] [Abstract][Full Text] [Related]
9. Snail-regulated genes in malignant melanoma.
Kuphal S; Palm HG; Poser I; Bosserhoff AK
Melanoma Res; 2005 Aug; 15(4):305-13. PubMed ID: 16034310
[TBL] [Abstract][Full Text] [Related]
10. p54nrb is a new regulator of progression of malignant melanoma.
Schiffner S; Zimara N; Schmid R; Bosserhoff AK
Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
[TBL] [Abstract][Full Text] [Related]
11. Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma.
Okada T; Lee AY; Qin LX; Agaram N; Mimae T; Shen Y; O'Connor R; López-Lago MA; Craig A; Miller ML; Agius P; Molinelli E; Socci ND; Crago AM; Shima F; Sander C; Singer S
Cancer Discov; 2016 Oct; 6(10):1148-1165. PubMed ID: 27577794
[TBL] [Abstract][Full Text] [Related]
12. Alpha10 integrin expression is up-regulated on fibroblast growth factor-2-treated mesenchymal stem cells with improved chondrogenic differentiation potential.
Varas L; Ohlsson LB; Honeth G; Olsson A; Bengtsson T; Wiberg C; Bockermann R; Järnum S; Richter J; Pennington D; Johnstone B; Lundgren-Akerlund E; Kjellman C
Stem Cells Dev; 2007 Dec; 16(6):965-78. PubMed ID: 18047418
[TBL] [Abstract][Full Text] [Related]
13. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.
Zehavi L; Schayek H; Jacob-Hirsch J; Sidi Y; Leibowitz-Amit R; Avni D
Mol Cancer; 2015 Mar; 14():68. PubMed ID: 25889255
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of alpha and beta integrin subunits in metastatic macrophage-melanoma fusion hybrids.
Chakraborty AK; Funasaka Y; Ichihashi M; Pawelek JM
Melanoma Res; 2009 Dec; 19(6):343-9. PubMed ID: 22760065
[TBL] [Abstract][Full Text] [Related]
15. The metastasis suppressor NME1 inhibits melanoma cell motility via direct transcriptional induction of the integrin beta-3 gene.
Leonard MK; Novak M; Snyder D; Snow G; Pamidimukkala N; McCorkle JR; Yang XH; Kaetzel DM
Exp Cell Res; 2019 Jan; 374(1):85-93. PubMed ID: 30458180
[TBL] [Abstract][Full Text] [Related]
16. Functional role of MIA in melanocytes and early development of melanoma.
Poser I; Tatzel J; Kuphal S; Bosserhoff AK
Oncogene; 2004 Aug; 23(36):6115-24. PubMed ID: 15208686
[TBL] [Abstract][Full Text] [Related]
17. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression.
Eisen T; Easty DJ; Bennett DC; Goding CR
Oncogene; 1995 Nov; 11(10):2157-64. PubMed ID: 7478537
[TBL] [Abstract][Full Text] [Related]
18. Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells.
Heimerl S; Bosserhoff AK; Langmann T; Ecker J; Schmitz G
Melanoma Res; 2007 Oct; 17(5):265-73. PubMed ID: 17885581
[TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic alterations of the APC gene in malignant melanoma.
Worm J; Christensen C; Grønbaek K; Tulchinsky E; Guldberg P
Oncogene; 2004 Jul; 23(30):5215-26. PubMed ID: 15133491
[TBL] [Abstract][Full Text] [Related]
20. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
